5 most recent filings and news items mentioning MBOT. Updated every 60 seconds.
OtherJun 23, 2026Positive
Microbot Medical's LIBERTY system secured its first adoption in Pennsylvania, expanding its footprint across seven U.S. states. This milestone by a leading academic health system bolsters commercial confidence, supporting plans to expand into the U.S. West Coast.
View filing at SEC.gov →
OtherJun 16, 2026Positive
Microbot Medical's LIBERTY Endovascular Robotic System will be added to Lovell Government Services' Federal Supply Schedule contract, enabling sales across Veterans Health Administration, Military Health System, and Indian Health Service facilities. The partnership expands the co
View filing at SEC.gov →
OtherJun 9, 2026Positive
Microbot Medical announced a major Michigan healthcare system adopted its LIBERTY Endovascular Robotic System, marking continued expansion into new U.S. regions following North Carolina adoption. The growth reflects increasing demand for robotic solutions in peripheral endovascul
View filing at SEC.gov →
OtherJun 2, 2026Positive
Microbot Medical announced adoption of its LIBERTY Endovascular Robotic System by a leading academic healthcare network in North Carolina, marking expansion into the South-Atlantic region. The company continues geographic penetration following full market release, demonstrating c
View filing at SEC.gov →
RegulatoryMay 26, 2026Positive
Microbot Medical announced that Israel's Ministry of Health AMAR Division approved marketing clearance for its LIBERTY Endovascular Robotic System, making Israel the second jurisdiction and first outside the U.S. to grant approval. The approval enables the company to obtain a Fre
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.